Benzinga | Oct 22, 2020 08:28AM EDT

Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $97

Credit Suisse analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $92 to $97.